Skip to menu Skip to content Skip to footer

2006

Conference Publication

Bone histology in alternate nightly home haemodialysis

van Eps, Carolyn, Jeffries, Janine, Diamond, Terrence, Anderson, John, Johnson, David, Campbell, Scott, Isbel, Nicole, Mudge, David and Hawley, Carmel (2006). Bone histology in alternate nightly home haemodialysis. 43rd ERA-EDTA Congress, Glasgow, Scotland, 15-18 July 2006 . Oxford, United Kingdom: Oxford University Press.

Bone histology in alternate nightly home haemodialysis

2006

Journal Article

Deceased donor renal transplantation - does side matter?

Johnson, David W., Mudge, David W., Kaisar, Mohammed O., Campbell, Scott B., Hawley, Carmel M., Isbel, Nicole M., Wall, Daryl, Griffin, Anthony, Preston, John and Nicol, David L. (2006). Deceased donor renal transplantation - does side matter?. Nephrology Dialysis Transplantation, 21 (9), 2583-2588. doi: 10.1093/ndt/gfl268

Deceased donor renal transplantation - does side matter?

2006

Conference Publication

A randomized, controlled trial of coiled versus straight swan neck tenckhoff catheters in peritoneal dialysis patients

Wong, J. S., Wiggins, K. J., Campbell, S. B., Isbel, N. M., Mudge, D. W., Hawley, C. M. and Johnson, D. W. (2006). A randomized, controlled trial of coiled versus straight swan neck tenckhoff catheters in peritoneal dialysis patients. 42nd Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, Australia, 14–18 August 2006. Hoboken, NJ United States: Wiley-Blackwell.

A randomized, controlled trial of coiled versus straight swan neck tenckhoff catheters in peritoneal dialysis patients

2006

Conference Publication

Effectiveness of a cardiovascular risk factor modification program in insulin-resistant renal transplant recipients

Armstrong, K., Johnson, D., De Silva, N., Pidcock, R., Orazio, L., Prins, J., Campbell, S., Hawley, C., Mudge, D., Marwick, T. and Isbel, N. (2006). Effectiveness of a cardiovascular risk factor modification program in insulin-resistant renal transplant recipients. 24th Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand, Canberra, Australia, 29–31 March 2006. Oxford, United Kingdom: John Wiley & Sons.

Effectiveness of a cardiovascular risk factor modification program in insulin-resistant renal transplant recipients

2006

Conference Publication

Effectiveness of a cardiovascular risk factor modification program in insulin-resistant renal transplant recipients

Armstrong, K., Johnson, D., De Silva, N., Pidcock, R., Orazio, L., Prins, J., Campbell, S., Hawley, C., Mudge, D., Marwick, T. and Isbel, N. (2006). Effectiveness of a cardiovascular risk factor modification program in insulin-resistant renal transplant recipients. 24th Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand, The Australian Academy of Science Canberra, ACT, Australia, 29–31 March 2006. Basingstoke, U. K.: Transplantation Society of Australia and New Zealand. doi: 10.1111/j.1440-1711.2006.01450.x

Effectiveness of a cardiovascular risk factor modification program in insulin-resistant renal transplant recipients

2006

Conference Publication

Outcomes of kidney transplant recipients on Warfarin at time of transplant

Wong, J. S., Campbell, S. B., Hawley, C. M., Johnson, D. W., Mudge, D. W. and Isbel, N. M. (2006). Outcomes of kidney transplant recipients on Warfarin at time of transplant. 42nd Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, Australia, 14–18 August 2006. Hoboken, NJ United States: Wiley-Blackwell.

Outcomes of kidney transplant recipients on Warfarin at time of transplant

2006

Conference Publication

Estimated donor GFR is the most important donor characteristic predicting graft function in recipients of live donor kidneys

Mudge, D. W., Hawley, C. M., Johnson, D., Isbel, N. M., Campbell, S. B., Griffin, A., Preston, J. and Nicol, D. (2006). Estimated donor GFR is the most important donor characteristic predicting graft function in recipients of live donor kidneys. 42nd Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, Australia, 14–18 August 2006. Hoboken, NJ United States: Wiley-Blackwell.

Estimated donor GFR is the most important donor characteristic predicting graft function in recipients of live donor kidneys

2006

Journal Article

Estimated donor glomerular filtration rate is the most important donor characteristic predicting graft function in recipients of kidneys from live donors

Hawley, Carmel M., Kearsley, Jamie, Campbell, Scott B., Mudge, David, Isbel, Nicole M., Johnson, David W., May, Kylie, Preston, John, Griffin, Anthony, Wall, Daryl, Burke, John, McTaggart, Steven J., Frohloff, Gayle and Nicol, David (2006). Estimated donor glomerular filtration rate is the most important donor characteristic predicting graft function in recipients of kidneys from live donors. Transplant International, 20 (1), 64-72. doi: 10.1111/j.1432-2277.2006.00400.x

Estimated donor glomerular filtration rate is the most important donor characteristic predicting graft function in recipients of kidneys from live donors

2006

Journal Article

Effect of previously failed kidney transplantation on peritoneal dialysis outcomes in the Australian and New Zealand patient populations

Badve, Sunil V., Hawley, Carmel M., McDonald, Stephen P., Mudge, David W., Rosman, Johan B., Brown, Fiona G., Johnson, David W. and ANZDATA Registry PD Working Comm (2006). Effect of previously failed kidney transplantation on peritoneal dialysis outcomes in the Australian and New Zealand patient populations. Nephrology Dialysis Transplantation, 21 (3), 776-783. doi: 10.1093/ndt/gfi248

Effect of previously failed kidney transplantation on peritoneal dialysis outcomes in the Australian and New Zealand patient populations

2005

Journal Article

Hepatic vein stenting for recurrent ascites in polycystic liver and kidney disease

Mudge, DW, Taylor, J and Bannister, KM (2005). Hepatic vein stenting for recurrent ascites in polycystic liver and kidney disease. Nephrology Dialysis Transplantation, 20 (11), 2566-2568. doi: 10.1093/ndt/gfi051

Hepatic vein stenting for recurrent ascites in polycystic liver and kidney disease

2005

Journal Article

Pharmacokinetics and normal scintigraphic appearance of 99mTc aprotinin

Sojan, SM, Smyth, DR, Tsopelas, C, Mudge, D, Collins, PJ and Chatterton, BE (2005). Pharmacokinetics and normal scintigraphic appearance of 99mTc aprotinin. Nuclear Medicine Communications, 26 (6), 535-539. doi: 10.1097/00006231-200506000-00009

Pharmacokinetics and normal scintigraphic appearance of 99mTc aprotinin

2005

Journal Article

Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus Mupirocin for the prevention of catheter-associated infections in hemodialysis patients

Johnson, David Wayne, van Eps, Carolyn, Mudge, David William, Wiggins, Kathryn Joan, Armstrong, Kirsty, Hawley, Carmel Mary, Campbell, Scott Bryan, Isbel, Nicole Maree, Nimmo, Graeme Robert and Gibbs, Harry (2005). Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus Mupirocin for the prevention of catheter-associated infections in hemodialysis patients. Journal of The American Society of Nephrology, 16 (5), 1456-1462. doi: 10.1681/ASN.2004110997

Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus Mupirocin for the prevention of catheter-associated infections in hemodialysis patients

2005

Journal Article

Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant

Atcheson, Bronwyn A., Taylor, Paul J., Mudge, David W., Johnson, David W., Hawley, Carmel M., Campbell, Scott B., Isbel, Nicole M., Pillans, Peter I. and Tett, Susan E. (2005). Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant. British Journal of Clinical Pharmacology, 59 (3), 271-280. doi: 10.1111/j.1365-2125.2004.02235.x

Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant

2005

Journal Article

Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearance

Mudge, David W., Rogers, Robyn, Hollett, Peter, Law, Belinda, Reiger, Kylie, Petrie, James J. B., Price, Lee, Johnson, David W., Campbell, Scott B., Isbel, Nicole M., Sullivan, Matthew and Hawley, Carmel M. (2005). Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearance. Nephrology Dialysis Transplantation, 20 (10), 2178-2185. doi: 10.1093/ndt/gfh987

Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearance

2005

Journal Article

Obliterative bronchiotitis or opportunistic infection? A diagnostic challenge in a renal transplant patient (Letter to the Editor)

Mudge, David W., Johnson, David W., Isbel, Nicole M., Campbell, Scott B., Nicol, David L. and Hawley, Carmel M. (2005). Obliterative bronchiotitis or opportunistic infection? A diagnostic challenge in a renal transplant patient (Letter to the Editor). Nephrology Dialysis Transplantation, 20 (1), 246-247. doi: 10.1093/ndt/gfh580

Obliterative bronchiotitis or opportunistic infection? A diagnostic challenge in a renal transplant patient (Letter to the Editor)

2004

Journal Article

Response: Iron Therapy in Renal Transplant Recipients

Johnson, David W., Mudge, David W., Atcheson, Bronwyn, Taylor, Paul J., Sturtevant, Joanna M., Hawley, Carmel M., Campbell, Scott B., Isbel, Nicole M., Nicol, David L. and Pillans, Peter (2004). Response: Iron Therapy in Renal Transplant Recipients. Transplantation, 78 (8), 1240-1240. doi: 10.1097/01.TP.0000137102.92992.5F

Response: Iron Therapy in Renal Transplant Recipients

2004

Journal Article

Coca-Cola and kangaroos (Case report)

Mudge, David W. and Johnson, David W. (2004). Coca-Cola and kangaroos (Case report). Lancet, 364 (9440), 1190-1190. doi: 10.1016/S0140-6736(04)17111-0

Coca-Cola and kangaroos (Case report)

2004

Journal Article

Severe Toxicity Associated with a Markedly Elevated Mycophenolic Acid Free Fraction in a Renal Transplant Recipient

Mudge, David, Atcheson, Bronwyn, Taylor, Paul, Pillans, Peter and Johnson, David (2004). Severe Toxicity Associated with a Markedly Elevated Mycophenolic Acid Free Fraction in a Renal Transplant Recipient. Therapeutic Drug Monitoring, 26 (4), 453-455. doi: 10.1097/00007691-200408000-00017

Severe Toxicity Associated with a Markedly Elevated Mycophenolic Acid Free Fraction in a Renal Transplant Recipient

2004

Journal Article

Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia

Atcheson, Bronwyn A., Taylor, Paul J., Kirkpatrick, Carl M. J., Duffull, Stephen B., Mudge, David W., Pillans, Peter I., Johnson, David W. and Tett, Susan E. (2004). Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia. Therapeutic Drug Monitoring, 26 (3), 284-286. doi: 10.1097/00007691-200406000-00011

Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia

2004

Journal Article

The effect of oral iron administration on mycophenolate mofetil absorption in renal transplant recipients: a randomized, controlled trial

Mudge, David W., Taylor, Paul J., Atcheson, Bronwyn A., Sturtevant, Joanna M., Hawley, Carmel M., Campbell, Scott B., Isbel, Nicole M., Nicol, David L., Pillans, Peter I. and Johnson, David W. (2004). The effect of oral iron administration on mycophenolate mofetil absorption in renal transplant recipients: a randomized, controlled trial. Transplantation, 77 (2), 206-209. doi: 10.1097/01.TP.0000100446.44001.00

The effect of oral iron administration on mycophenolate mofetil absorption in renal transplant recipients: a randomized, controlled trial